View All News

Allentown Pharma Firm Hopes To Soon Have Oral Vaccine To Market

July 20, 2022

With Phase 1 testing now complete and showing positive results, U.S.

Specialty Formulations of Allentown is moving forward with the oral COVID-19 vaccine that it is producing.

Read More

Comments are closed.

About the Author

Written by the GamePlanX Network of Experts - https://gameplanx.com, a multidisciplinary team specializing in outcome‑driven strategic growth, regulatory‑compliant digital marketing, and AI‑enabled operational optimization across industries. For this article, the GamePlanX team contributes expertise specifically relevant to USSF’s cGMP pharmaceutical manufacturing operations, botanical injectables, and clinical education initiatives.